BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25659668)

  • 1. Review for carrageenan-based pharmaceutical biomaterials: favourable physical features versus adverse biological effects.
    Liu J; Zhan X; Wan J; Wang Y; Wang C
    Carbohydr Polym; 2015 May; 121():27-36. PubMed ID: 25659668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring carrageenan: From seaweed to biomedicine-A comprehensive review.
    Das IJ; Bal T
    Int J Biol Macromol; 2024 May; 268(Pt 2):131822. PubMed ID: 38677668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight on structure-property relationships of carrageenan from marine red algal: A review.
    Jiang JL; Zhang WZ; Ni WX; Shao JW
    Carbohydr Polym; 2021 Apr; 257():117642. PubMed ID: 33541666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on synthesis, properties and applications of natural polymer based carrageenan blends and composites.
    Zia KM; Tabasum S; Nasif M; Sultan N; Aslam N; Noreen A; Zuber M
    Int J Biol Macromol; 2017 Mar; 96():282-301. PubMed ID: 27914965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrageenans-Sulfated Polysaccharides from Red Seaweeds as Matrices for the Inclusion of Echinochrome.
    Yermak IM; Mischchenko NP; Davydova VN; Glazunov VP; Tarbeeva DV; Kravchenko AO; Pimenova EA; Sorokina IV
    Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29104249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrageenan gel beads for echinochrome inclusion: Influence of structural features of carrageenan.
    Yermak IM; Gorbach VI; Karnakov IA; Davydova VN; Pimenova EA; Chistyulin DА; Isakov VV; Glazunov VP
    Carbohydr Polym; 2021 Nov; 272():118479. PubMed ID: 34420738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrageenan: a natural seaweed polysaccharide and its applications.
    Prajapati VD; Maheriya PM; Jani GK; Solanki HK
    Carbohydr Polym; 2014 May; 105():97-112. PubMed ID: 24708958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two natural glucomannan polymers, from Konjac and Bletilla, as bioactive materials for pharmaceutical applications.
    Wang Y; Liu J; Li Q; Wang Y; Wang C
    Biotechnol Lett; 2015 Jan; 37(1):1-8. PubMed ID: 25214219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrageenan: Drug Delivery Systems and Other Biomedical Applications.
    Pacheco-Quito EM; Ruiz-Caro R; Veiga MD
    Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33238488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in exploiting carrageenans as a versatile functional material for promising biomedical applications.
    Liu F; Duan G; Yang H
    Int J Biol Macromol; 2023 Apr; 235():123787. PubMed ID: 36858089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrageenan and its applications in drug delivery.
    Li L; Ni R; Shao Y; Mao S
    Carbohydr Polym; 2014 Mar; 103():1-11. PubMed ID: 24528694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiherpetic Activity of Carrageenan Complex with Echinochrome A and Its Liposomal Form.
    Krylova NV; Gorbach VI; Iunikhina OV; Pott AB; Glazunov VP; Kravchenko AO; Shchelkanov MY; Yermak IM
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into the Structure of Kappa/Beta-Carrageenan: A Novel Potential Inhibitor of HIV-1.
    Yermak I; Anastyuk S; Kravchenko A; Helbert W; Glazunov V; Shulgin A; Spirin P; Prassolov V
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrageenan activates monocytes via type-specific binding with interleukin-8: an implication for design of immuno-active biomaterials.
    Chan WI; Zhang G; Li X; Leung CH; Ma DL; Dong L; Wang C
    Biomater Sci; 2017 Feb; 5(3):403-407. PubMed ID: 28106172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrageenan films as promising mucoadhesive ocular drug delivery systems.
    Volod'ko AV; Son EY; Glazunov VP; Davydova VN; Alexander-Sinkler EI; Aleksandrova SA; Blinova MI; Yermak IM
    Colloids Surf B Biointerfaces; 2024 May; 237():113854. PubMed ID: 38502974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Algal Phycocolloids: Bioactivities and Pharmaceutical Applications.
    Lomartire S; Gonçalves AMM
    Mar Drugs; 2023 Jun; 21(7):. PubMed ID: 37504914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel porous scaffolds of pH responsive chitosan/carrageenan-based polyelectrolyte complexes for tissue engineering.
    Araujo JV; Davidenko N; Danner M; Cameron RE; Best SM
    J Biomed Mater Res A; 2014 Dec; 102(12):4415-26. PubMed ID: 24677767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of κ-carrageenan with poly(2-hydroxypropylmethacrylamide) through microwave induced graft copolymerization: Characterization and swelling features.
    Geyik G; Işıklan N
    Int J Biol Macromol; 2023 Apr; 235():123888. PubMed ID: 36870636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical Properties and Antiherpetic Activity of κ-Carrageenan Complex with Chitosan.
    Davydova VN; Krylova NV; Iunikhina OV; Volod'ko AV; Pimenova EA; Shchelkanov MY; Yermak IM
    Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.